Searching…
Jul 17, 2025 · ABL2 (ABL Proto-Oncogene 2, Non-Receptor Tyrosine Kinase) is a Protein Coding gene. Diseases associated with ABL2 include Glioma Susceptibility 1 and Leukemia, Acute Lymphoblastic.
ABL2 is a cytoplasmic tyrosine kinase which is closely related to but distinct from ABL1. The similarity of the proteins includes the tyrosine kinase domains and extends amino-terminal to include the SH2 and SH3 domains.
Feb 19, 2025 · Platelet-derived growth factor receptor beta activates Abl2 via direct binding and phosphorylation. The ABL2 kinase regulates an HSF1-dependent transcriptional program required for lung adenocarcinoma b...
在众多 酪氨酸激酶抑制剂 （TKI）耐药机制中， ABL基因突变 是唯一能够指导临床治疗决策的因素。 根据 欧洲白血病网 （ELN）和 美国国家综合癌症网络 （NCCN）指南，当CML患者出现非最佳疗效或治疗失败时，推荐进行ABL突变检测。
ABL2基因编码Abelson家族非受体酪氨酸蛋白激酶，与c-abl癌基因高度相似。 页面提供物种序列比对、转录本、蛋白质、表达量及疾病模型研究数据。
BACKGROUND: Diseases associated with Abelson-related gene (also called ABL2) include leukemia; furthermore, previous researches have studied the expressions and functions of ABL2 in different types of malignancies and...
该基因编码非受体酪氨酸蛋白激酶 Abelson 家族的成员。 该蛋白与 c-abl 致癌基因 1 蛋白高度相似，包括酪氨酸激酶、SH2 和 SH3 结构域，它通过其 C 末端肌动蛋白和微管结合序列在细胞骨架重排中发挥作用。
